Cardiovascular Innovations and Applications (Nov 2022)

Inappropriate Activation of TLR4/NF-κB is a Cause of Heart Failure

  • Jiedong Zhou,
  • Hui Lin,
  • Tingting Lv,
  • Jinjin Hao,
  • Hanlin Zhang,
  • Shimin Sun,
  • Juntao Yang,
  • Jufang Chi,
  • Hangyuan Guo

DOI
https://doi.org/10.15212/CVIA.2022.0020
Journal volume & issue
Vol. 7, no. 1
p. 989

Abstract

Read online

Significance: Heart failure, a disease with extremely high incidence, is closely associated with inflammation and oxidative stress. The Toll-like receptor 4 (TLR4)/nuclear factor kappa-B (NF-κB) pathway plays an important role in the occurrence and development of heart failure. Recent advances: Previous studies have shown that TLR4/NF-κB causes heart failure by inducing oxidative stress and inflammation; damaging the endothelia; promoting fibrosis; and inducing myocardial hypertrophy, apoptosis, pyroptosis, and autophagy. Critical issues: Understanding the pathogenesis of heart failure is essential for the treatment of this disease. In this review, we outline the mechanisms underlying TLR4/NF-κB pathway-mediated heart failure and discuss drugs that alleviate heart failure by regulating the TLR4/NF-κB pathway. Future directions: During TLR4/NF-κB overactivation, interventions targeting specific receptor antagonists may effectively alleviate heart failure, thus providing a basis for the development of new anti-heart failure drugs.